Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;133(3):664-9.e5.
doi: 10.1016/j.jaci.2013.12.1042. Epub 2014 Jan 31.

Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids

Heung-Woo Park  1 , Amber Dahlin  2 , Szeman Tse  2 , Qing Ling Duan  2 , Brooke Schuemann  2 , Fernando D Martinez  3 , Stephen P Peters  4 , Stanley J Szefler  5 , John J Lima  6 , Michiaki Kubo  7 , Mayumi Tamari  7 , Kelan G Tantisira  8
Affiliations

Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids

Heung-Woo Park et al. J Allergy Clin Immunol. 2014 Mar.

Abstract

Background: To date, genome-wide association studies (GWASs) of inhaled corticosteroid (ICS) response in asthmatic patients have focused primarily on lung function and exacerbations.

Objective: We hypothesized that GWAS analysis could identify novel genetic markers predicting a symptomatic response to ICSs.

Methods: We analyzed differences in asthma symptoms in response to ICSs in 124 white children from the Childhood Asthma Management Program (CAMP) trial using scores from diary cards. Of the 440,862 single nucleotide polymorphisms (SNPs) analyzed, the top 100 ranked SNPs were pursued for replication initially in subjects from the pediatric Childhood Asthma Research and Education trials (77 white children) and then in subjects from the adult Asthma Clinical Research Network (110 white adults) and Leukotriene Modifier or Corticosteroid or Corticosteroid-Salmeterol trials (110 white adults).

Results: The lowest P value for GWAS analysis in the CAMP trial was 8.94 × 10(-8) (rs2388639). Of the 60 SNPs available in the Childhood Asthma Research and Education Network trials, rs1558726 (combined P = 1.02 × 10(-5)), rs2388639 (combined P = 8.56 × 10(-9)), and rs10044254 (combined P = 9.16 × 10(-8)) independently replicated. However, these 3 SNPs were not additionally replicated in the adult asthmatic patients of the remaining trials. rs10044254 lies in the intronic region of F-box and leucine-rich repeat protein 7 (FBXL7) and is associated with decreased expression in immortalized B cells derived from CAMP participants.

Conclusions: We have identified a novel SNP, rs10044254, associated with both decreased expression of FBXL7 and improved symptomatic response to ICSs in 2 independent pediatric cohorts. Our results suggest that there might be a specific genetic mechanism regulating symptomatic response to ICSs in children that does not carry over to adults.

Keywords: Asthma; child; glucocorticoid; pharmacogenomics; polymorphism.

PubMed Disclaimer

Conflict of interest statement

Disclosure of potential conflict of interest: The rest of the authors declare that they have no relevant conflicts of interest.

Figures

Fig 1
Fig 1
Changes in asthma symptom scores after ICS treatment in the 2 pediatric asthma populations (CAMP and CARE) genotyped for rs10044254 and stratified by genotype status. Subjects in the CAMP and CARE trials who carried 2 variant alleles showed increases in asthma symptom scores after ICS treatment, whereas subjects that were homozygous for the reference allele and heterozygous showed decreases. Data represent medians (IQRs), and small circles represent subjects who were outliers from the first and the third quartiles.
Fig 2
Fig 2
FBXL7 gene expression in response to dexamethasone stimulation in immortalized B cells of the CAMP subject stratified by rs10044254 genotype. Reference represents expression data of B cells from the subjects with the reference allele, and Variant indicates expression data of B cells from the subjects with the variant allele (allelic model). Data represent medians (IQRs), and small circles represent subjects who were outliers from the first and the third quartiles.
See this image and copyright information in PMC

References

    1. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:24. - PMC - PubMed
    1. The Global Initiative for Asthma (GINA) The guideline for asthma management and prevention. [Accessed January 28, 2013];2010 Available at: http://www.ginasthma.org/guidelines-pocket-guide-for-asthma-management.html.
    1. The National Asthma Education and Prevention Program (NAEPP) National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. [Accessed January 28, 2013];2007 Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    1. British Thoracic Society, Scottish Intercollegiateh Guidelines Network. British guideline on the management of asthma. [Accessed January 28, 2013]; Available at: http://www.sign.ac.uk/pdf/sign101.pdf.
    1. Boushey HA. Effects of inhaled corticosteroids on the consequences of asthma. J Allergy Clin Immunol. 1998;102(Suppl):S5–16. - PubMed

Publication types